SAN DIEGO, Oct. 7 /PRNewswire-FirstCall/ —ACADIA Pharmaceuticals Inc.(Nasdaq: ACAD) announced today that it will present at the Bio EmergingCompany Investor Forum on Wednesday, October 13, at 2:20 pm PDT. ACADIA'spresentation will be given by Uli Hacksell, Ph.D., its Chief ExecutiveOfficer, and will be webcast from the Sheraton Palace Hotel in San Francisco.
A live webcast of ACADIA's presentation will be accessible on thecompany's website, www.acadia-pharm.com, under the investor relations sectionand an archived recording will be available on the website throughOctober 27, 2004.
About ACADIA Pharmaceuticals
ACADIA Pharmaceuticals is a biopharmaceutical company utilizing innovativescience to fuel drug discovery and clinical development of novel treatmentsfor central nervous system disorders. ACADIA currently has five drug programsin clinical and preclinical development directed at large unmet medical needsand major commercial markets, including Parkinson's disease, schizophrenia,chronic pain, and glaucoma. Using its proprietary drug discovery platform,ACADIA has discovered all of the drug candidates in its product pipeline.ACADIA's headquarters and biological research facilities are located inSan Diego, California and its chemistry research facilities are located inCopenhagen, Denmark.
Contact:
ACADIA Pharmaceuticals Inc.
Thomas H. Aasen, Vice President and Chief Financial Officer+1 858-558-2871ir@acadia-pharm.com